{"id":"NCT01746862","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)","officialTitle":"A Randomized, Open-label, Two-arm Parallel Group, No Treatment Group-controlled, Multicenter Phase III Study to Evaluate the Safety and Efficacy of Saizen® 0.067 mg/kg/Day Subcutaneous Injection in Children With Idiopathic Short Stature","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2014-08","completion":"2015-03","firstPosted":"2012-12-11","resultsPosted":"2016-10-18","lastUpdate":"2016-10-18"},"enrollment":90,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Idiopathic Short Stature"],"interventions":[{"type":"DRUG","name":"Saizen®","otherNames":["Somatropin","r-hGH"]},{"type":"DRUG","name":"Saizen®","otherNames":["Somatropin","r-hGH"]}],"arms":[{"label":"Saizen Test Group","type":"EXPERIMENTAL"},{"label":"Saizen Control Group","type":"ACTIVE_COMPARATOR"}],"summary":"This is an open-label, multi-center, randomized, two-arm parallel, no-treatment group controlled (only for the first 6 months), Phase 3 study in children with ISS. The subjects will be treated with 0.067 milligram/kilogram/day (mg/kg/day) of Saizen®, weight base dose, for 12 months (12 months of treatment in the test group, and 6 months of no treatment and then 6 months of treatment in the control group).","primaryOutcome":{"measure":"Change From Baseline in Height Velocity at Month 6 Using Last Observation Carried Forward (LOCF) Method","timeFrame":"Baseline, Month 6","effectByArm":[{"arm":"Saizen Test Group","deltaMin":5.63,"sd":1.62},{"arm":"Saizen Control Group","deltaMin":4.94,"sd":1.91}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":19},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":["30110706"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":59},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Pyrexia","Rhinitis","Bronchitis"]}}